Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of June 02, 2025, AstraZeneca (AZN) has a market cap of $222.70 billion USD. According to our data, AstraZeneca is ranked No.58 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jun 02, 2025 | $222.70 B |
11.20%
|
| Dec 31, 2024 | $200.28 B |
-0.62%
|
| Dec 29, 2023 | $201.52 B |
1.44%
|
| Dec 30, 2022 | $198.66 B |
19.16%
|
| Dec 31, 2021 | $166.72 B |
19.73%
|
| Dec 31, 2020 | $139.25 B |
3.12%
|
| Dec 31, 2019 | $135.03 B |
35.68%
|
| Dec 31, 2018 | $99.52 B |
13.86%
|
| Dec 29, 2017 | $87.41 B |
33.24%
|
| Dec 30, 2016 | $65.60 B |
-15.82%
|
| Dec 31, 2015 | $77.92 B |
0.51%
|
| Dec 31, 2014 | $77.53 B |
23.55%
|
| Dec 31, 2013 | $62.75 B |
33.17%
|
| Dec 31, 2012 | $47.12 B |
8.51%
|
| Dec 30, 2011 | $43.42 B |
6.05%
|
| Dec 31, 2010 | $40.95 B |
3.51%
|
| Dec 31, 2009 | $39.56 B |
20.34%
|
| Dec 31, 2008 | $32.87 B |
0.18%
|
| Dec 31, 2007 | $32.81 B |
-17.48%
|
| Dec 29, 2006 | $39.76 B |
13.31%
|
| Dec 30, 2005 | $35.09 B |
36.91%
|
| Dec 31, 2004 | $25.63 B |
-23.44%
|
| Dec 31, 2003 | $33.48 B |
40.83%
|
| Dec 31, 2002 | $23.78 B |
-23.23%
|
| Dec 31, 2001 | $30.97 B |
-7.91%
|
| Dec 29, 2000 | $33.63 B |
28.68%
|
| Dec 31, 1999 | $26.13 B |
-5.66%
|
| Dec 31, 1998 | $27.70 B |
27.01%
|
| Dec 31, 1997 | $21.81 B |
31.74%
|
| Dec 31, 1996 | $16.56 B |
47.05%
|
| Dec 29, 1995 | $11.26 B |
47.31%
|
| Dec 30, 1994 | $7.64 B |
15.32%
|
| Dec 31, 1993 | $6.63 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Pfizer
PFE
|
$133.09 B |
-0.057 B
|
USA
|
 Johnson & Johnson
JNJ
|
$373.40 B |
-0.005 M
|
USA
|
 Merck
MRK
|
$190.56 B |
-0.025 B
|
USA
|
 Novartis
NVS
|
$230.14 B |
-0.007 M
|
Switzerland
|
 GlaxoSmithKline
GSK
|
$84.14 B |
0.003 M
|
UK
|
 Sanofi
SNY
|
$125.43 B |
5.543 B
|
France
|
 Bristol-Myers Squibb
BMY
|
$99.18 B |
-0.004 M
|
USA
|
 AbbVie
ABBV
|
$329.43 B |
0.012 M
|
USA
|
 Amgen
AMGN
|
$154.43 B |
0.000 M
|
USA
|
 Eli Lilly
LLY
|
$664.56 B |
-0.020 M
|
USA
|
 Takeda Pharmaceutical
TAK
|
$46.89 B |
-0.002 M
|
Japan
|
 Biogen
BIIB
|
$19.31 B |
-0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$53.32 B |
0.897 B
|
USA
|
| Market Cap | = | AZN Stock Price | * | AZN Shares Outstanding |
| = | $71.83 | * | 3.10 B | |
| = | $222.70 B |